GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mochida Pharmaceutical Co 4534.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

3,255

+2.84%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Mochida Pharmaceutical Co

Its shares trade on Tokyo Stock Exchange under the ticker 4534.T. It has been listed since 13 May 1963. In the fiscal year to 31 March 2026, it reported revenue of ¥116.95bn and net income of ¥7.90bn. At that date it held total assets of ¥182.72bn and shareholders' equity of ¥140.33bn.

Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. The company is headquartered in Shinjuku, Tokyo-To. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The firm also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
13 May 1963
Employees
1,581

Leadership

Pay as last reported

  • Mr. Naoyuki MochidaPresident, Representative Director, since 1997
  • Mr. Chu SakataVice President, Executive Vice President, Representative Director, since 2011
  • Mr. Motoi MitsuishiSenior Managing Executive Officer, Chief Director of Planning and Management, Director, since 2023
  • Mr. Keiichi SagisakaSenior Managing Executive Officer, Director, since 2007
  • Dr. Junichi SakakiSenior Managing Executive Officer, Director, since 2012
  • Dr. Yutaka KawakamiManaging Executive Officer, Director, since 2015
  • Dr. Junichi NezuManaging Executive Officer, Director, since 2023
  • Mr. Taiji HayanoManaging Executive Officer, Chief Director of Pharmaceutical Development
  • Dr. Yoshitaka HosakaManaging Executive Officer, Chief Director of Business Promotion
  • Mr. Tomokazu MatsusueManaging Executive Officer, Chief Director of Business Development
  • Mr. Hitoshi MizunoManaging Executive Officer, Chief Director of Biomaterial Business, Director of Medical Device Product Development
  • Mr. Masaaki NaotsukaManaging Executive Officer

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Mochida Pharmaceutical Co Ltd possesses several strengths that contribute to its competitive advantage:

Weaknesses

  • Despite its strengths, Mochida Pharmaceutical Co Ltd also faces certain weaknesses, which are areas that may hinder its growth and success:

Opportunities

  • Mochida Pharmaceutical Co Ltd can leverage the following opportunities to drive growth and expand its market presence:

Threats

  • Mochida Pharmaceutical Co Ltd should be mindful of the following threats that could impact its business operations and market position:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.